Lifeforce Capital
Venture capitalChevy Chase Β· Series AβSeries C
Investment thesis
Lifeforce Capital is a venture capital firm that invests in software companies disrupting major healthcare markets.
Source: firm website, verified Jul 21, 2026.
What they invest in
from 24 of 50 portfolio companiesHealthtech Γ19Biotech Γ13Digital Health Γ13Medical Devices Γ13AI & Machine Learning Γ10Deep Tech Γ7Mental Health Γ3Impact & Social Good Γ1
HQs:United StatesΓ11United KingdomΓ1
Investments Β· 50 tracked
founders shown can be your intro pathAspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease. The company is a clinical-stage biotechnology firm focused on personalized neuron replacement therapies.
BiotechDeep TechDigital HealthMedical Devices<UNKNOWN>, US
AndrΓ©s Bratt-Leal(Co-Founder and Senior Vice President, Research & Development)Damien McDevitt(President and Chief Executive Officer)
64x develops infrastructure and manufacturing systems for next-generation medicines, focusing on genetic engineering, cell line development, and computational biology to enable scalability of advanced therapies.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Lexi Rovner(Co-founder & CEO)in
Able Health provides software for physician organizations to administer value-based care programs, including quality measure calculation and health plan coordination to reduce administrative overhead.
HealthtechSan Francisco, US
Rachel Katz(Founder/CEO)inSteve Daniels(Founder/President)in
Bayesian Health develops clinical artificial intelligence for real-time patient monitoring and clinical decision support. The company serves healthcare providers and care teams with data-driven tools to improve patient outcomes.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Dr. Suchi Saria
Circle Pharma develops cancer treatments using macrocycle therapies designed to reduce side effects compared to conventional therapies. The company serves cancer patients and their caregivers globally.
BiotechDigital HealthHealthtechMedical Devices
David J. Earp(President & CEO)Matthew P. Jacobson(Co-founder)
Cityblock provides primary care and health services focused on making healthcare accessible as a basic right, particularly serving underserved and marginalized communities with an emphasis on trust-based, inclusive care.
Digital HealthHealthtechImpact & Social GoodMental Health
Dr. Toyin Ajayi(Co-founder & CEO)
Clover Health is a health insurance provider offering low-cost plans with minimal premiums, copays, and prescription drug costs. The company uses technology called Clover Assistant to help members focus on healthier living.
Digital HealthHealthtechInsurTech
Eko develops FDA-cleared digital stethoscopes and AI-powered software that enables healthcare professionals to detect and diagnose cardiovascular disease with greater accuracy. The company serves clinicians and health systems seeking advanced diagnostic tools for cardiac care.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Connor Landgraf(Co-Founder and CEO)Tyler CrouchJason Bellet(Co-Founder and Chief Business Officer)
Synapticure provides virtual care services for individuals and families with neurodegenerative conditions, offering access to expert-led care, cutting-edge treatments, clinical trials, and wraparound support across all 50 US states through a network of local partners.
AI & Machine LearningDigital HealthHealthtechChicago, US
Brian Wallach(Co-Founder, Board Co-Chair)inJaimie Hatcher-Martin(Dr.)Sandra Abrevaya(Co-Founder, Chief Executive Officer)Peter(Co-Founder, Life Sciences)
One Medical is a primary care practice delivering in-office and virtual care across 19 U.S. cities, serving individual members and employees of over 8,500 companies through a membership model.
Digital HealthHealthtechWellness & FitnessSan Francisco, US
Started by some of the best-trained physicians in the country
Notable Labs operates an automated laboratory that tests combinations of existing drugs against individual patients' blood cancer cells to identify effective treatment options for patients whose cancers have become resistant to standard therapies.
BiotechHealthtechMedical DevicesSan Francisco, US
Ochre Bio develops RNA therapeutics and drug discovery platforms targeting liver disease, combining proprietary human liver datasets with AI-driven causal prediction and human tissue validation models. The company aims to address the global shortage of liver transplants by developing new treatment options for liver fibrosis and cirrhosis.
AI & Machine LearningBiotechHealthtechMedical DevicesLondon, GB
Chinwe UkomaduElaine SullivanEliot ForsterJack Castle
Positive Development provides autism therapy and developmental care services for neurodivergent children and their families. The company delivers evidence-based care through a multidisciplinary team approach focused on supporting both the child and whole family.
Digital HealthHealthtechMedical DevicesMental Health
<UNKNOWN>(Co-founder & Chief Executive Officer)
Postera uses artificial intelligence and computational chemistry to accelerate drug discovery for pharmaceutical companies. The platform combines machine learning, medicinal chemistry, and software engineering to improve the drug development process.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesBoston, US
Sempre Health provides digital health solutions focused on patient engagement and outcomes management for the healthcare industry. The company works with payers and life sciences organizations to improve patient success and health outcomes.
Digital HealthHealthtech
<UNKNOWN>
Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells. The company is a clinical-stage biotech firm leveraging proprietary platform technology across multiple cell types and modalities.
BiotechDeep TechMedical Devices
Tim Lu(Co-Founder and Chief Executive Officer)Kanya Rajangam(President, Head of Research & Development and Chief Medical Officer)
Sonoma Biotherapeutics develops engineered regulatory T cell therapies to treat autoimmune and inflammatory diseases. The company uses proprietary platform technologies to create targeted and durable Treg cell therapies.
BiotechHealthtechMedical Devices
Sunstone Therapies is a clinical research organization with expertise in psychedelic and consciousness research, operating with teams that include researchers from institutions like Johns Hopkins Center for Psychedelic and Consciousness Research and the Dana-Farber Cancer Institute. The company focuses on patient-centered care with clinical rigor in the mental health and oncology spaces.
BiotechDigital HealthHealthtechMedical DevicesMental Health
Manish Agrawal(CEO)
Valo combines AI, causal inference techniques, and chemistry to accelerate drug discovery and development by identifying disease targets in human data and rapidly engineering novel small molecules.
AI & Machine LearningBiotechDeep Tech
Topography Health operated a site business unit that was acquired by FOMAT Medical Research.
Medical Devices
Verge Labs builds AI models trained on multimodal human patient data to predict drug targets and patient populations for clinical development, primarily in neuroscience and central nervous system (CNS) disease. The company applies frontier AI techniques to drug discovery for life sciences and pharmaceutical development.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSan Francisco, US
Alice Zhang(CEO)inEmily Ripka(Head of Product & Engineering)
Frequently asked questions
- What stage does Lifeforce Capital invest at?
- Lifeforce Capital invests at the Series A, Series B, Series C stages.
- What sectors does Lifeforce Capital focus on?
- Lifeforce Capital focuses on Healthtech, SaaS.
- Where is Lifeforce Capital located?
- Lifeforce Capital is headquartered in Chevy Chase, US.
Similar investors
83North is a lean venture capital partnership of four equal general partners that has operated for 19 years. The firm invests globally across the US, Europe, and Israel, and in 2025 raised what it describes as its final fund, shifting focus toward selectively pursuing new opportunities while supporting existing portfolio companies.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Bessemer Venture Partners is a venture capital firm with a 50-year history supporting entrepreneurs in building enduring companies globally. The firm draws on deep operational expertise and advisory relationships to support portfolio companies through their growth journey.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.